文献速递泌尿生殖妇产影像CTMR

CT与MRI能否区分卵巢浆液性交界性肿瘤微乳头亚型与典型亚型

Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
PubMed 文献 · Abdom Radiol (NY) · 2021-03-03

该回顾性研究纳入47例卵巢浆液性交界性肿瘤(SBT)患者,其中典型SBT 30例(58个病灶)、微乳头亚型(SBT-MP)17例(26个病灶),评估术前CT与MRI特征。结果显示两亚型在形态学模式上差异显著(P<0.001),典型SBT多见不规则实性肿瘤及含内部分支的乳头状结构,SBT-MP多见单房囊肿伴壁结节;钙化在典型SBT更常见(64.86% vs 30%,P<0.05),出血在SBT-MP更常见(90% vs 54.05%,P<0.05)。结论认为形态学与内部结构是区分两亚型的主要影像特征。

要点

  • 典型SBT在CT上多表现为不规则实性肿瘤(56.76%),SBT-MP多为单房囊肿伴壁结节(70%)。
  • MRI上典型SBT多见含内部分支的乳头状结构(80.95%),T2WI呈稍高信号乳头伴低信号内部分支。
  • 钙化更多见于典型SBT(64.86% vs 30%),出血更多见于SBT-MP(90% vs 54.05%)。

关键影像表现/征象

  • CT上典型SBT主要形态为不规则实性肿瘤(21/37,56.76%),SBT-MP主要为单房囊肿伴壁结节(14/20,70%)。
  • MRI上典型SBT主要形态为含内部分支的乳头状结构(17/21,80.95%),SBT-MP主要为单房囊肿伴壁结节(4/6,66.67%)。
  • 含内部分支的乳头状结构在T2WI上表现为稍高信号乳头状结构伴低信号内部分支。
  • 钙化在典型SBT中更多见(24/37,64.86% vs SBT-MP 6/20,30%,P<0.05)。
  • 出血在典型SBT中较少见(20/37,54.05% vs SBT-MP 18/20,90%,P<0.05)。

诊断标准与关键数值

  • 形态学模式在CT和MR图像上两亚型间差异显著(P<0.001)。
  • 两亚型实性成分增强后均呈流入型强化,CT与MRI表现一致,仅2例SBT-MP因完全局灶性出血在MR图像上无强化。

临床应用与阅片要点

  • 阅片时注意评估肿瘤形态学模式:不规则实性肿瘤提示典型SBT,单房囊肿伴壁结节提示SBT-MP可能。
  • MRI上发现含内部分支的乳头状结构(T2WI稍高信号乳头伴低信号分支)提示典型SBT。
  • 钙化更支持典型SBT,出血更支持SBT-MP,可结合CT与MRI表现综合判断。
  • 实性成分增强后流入型强化为两亚型共同表现,鉴别价值有限。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the computed tomography (CT) and magnetic resonance imaging (MRI) characteristics of ovarian serous borderline tumors (SBTs), and evaluate whether CT and MRI can be used to distinguish micropapillary from typical subtypes.

MATERIALS AND METHODS: We retrospectively reviewed the clinical features and CT and MR imaging findings of 47 patients with SBTs encountered at our institute from September 2013 to December 2019. 30 patients with 58 histologically proven typical SBT and 17 patients with 26 micropapillary SBT were reviewed. Preoperative CT and MR images were evaluated, by two observers in consensus for the laterality, maximum diameter (MD), morphology patterns, internal architecture, attenuation or signal intensity, ADC value, enhancement patterns of solid portions (SP), and extra-ovarian imaging features.

RESULTS: The median age were similar between typical SBT and SBT-MP (32.5 years, 36 years, respectively, P>0.05). Morphology patterns between two subtypes were significantly different on CT and MR images (P < 0.001). Irregular solid tumor (21/37, 56.76%) was the major morphology pattern of typical SBT tumor, while unilocular cyst with mural nodules (14/20, 70%) was the major morphology pattern of SBT-MP on CT images. Similarly, papillary architecture with internal branching (PA&IB) (17/21, 80.95%) was the major morphology pattern of typical SBT tumor, while unilocular cyst with mural nodules (4/6, 66.67%) was the major pattern of SBT-MP on MR images. PA&IB all showed slightly hyperintense papillary architecture with hypointense internal branching on T2-weighted MRI. More calcifications were found in typical SBT (24/37, 64.86%) than SBT-MP mass lesion (6/20, 30%) (P < 0.05). Hemorrhage was less frequently visible in (20/37, 54.05%) typical SBT lessons than SBT-MP mass lesion (18/20, 90%) (P < 0.05). The ovarian preservation is more seen in typical SBT (38/58, 65.52%) than SBT-MP (12/28, 42.86%) in our series (P < 0.05). Mean ADC value of solid portions (papillary architecture and mural nodules) was 1.68 (range from 1.44 to 1.85) × 10-3 mm2/s for typical SBT and 1.62 (range from 1.45 to 1.7) × 10-3 mm2/s for that of SBT-MP. The solid components of the two SBT subtypes showed wash-in appearance enhancements after contrast injection both in CT and MR images except 2 of SBT-MP with no enhancement as complete focal hemorrhage on MR images.

CONCLUSION: Morphology and internal architecture are two major imaging features that can help to distinguish between SBT-MP and typical SBT.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Zhang Y, Tan J, Wang J, et al. Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors? Abdom Radiol (NY). 2021. PMID: 33660041. doi:10.1007/s00261-021-03000-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。